Related Experiment Video
Updated: Nov 1, 2025
04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
11.8K
Early Peanut Introduction and Testing: A Framework for General Pediatrician Beliefs and Practices
Angela Chang1, Michael D Cabana1,2, Taylor N LaFlam1
1Department of Pediatrics and UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, California, USA.
Pediatric Allergy, Immunology, and Pulmonology
|June 18, 2021
Summary
Pediatricians face barriers recommending early peanut introduction for infants, including lack of awareness and resources. Addressing these requires education, resources, and parental support for guideline adherence.
Area of Science:
- Pediatric Allergy and Immunology
- Public Health Guidelines
- Qualitative Research Methods
Background:
- Infant feeding guidelines for peanut allergy prevention have shifted significantly since 2001.
- Current recommendations (2015) advocate for early peanut introduction (4-11 months) in high-risk infants.
Purpose of the Study:
- To explore pediatrician beliefs, practices, facilitators, and barriers related to infant peanut introduction and allergy testing.
- To develop a conceptual framework for understanding early peanut introduction uptake.
Main Methods:
- Qualitative study involving semi-structured interviews with 18 general pediatricians in Northern California (2017).
- Grounded theory methodology was used for data coding and framework development.
Main Results:
- Identified barriers include lack of awareness, agreement, resources, and outcome expectancy among pediatricians.
- A framework highlights the need for pediatrician knowledge, agreement, resources, and parental buy-in for guideline success.
Conclusions:
- Pediatrician apprehension exists regarding early peanut introduction recommendations due to various barriers.
- A multifaceted approach addressing provider awareness, primary care resources, and subspecialty collaboration is crucial for improving guideline implementation.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
01:29Drug Dosing: Infants and Children
65
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
65
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
55
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
01:28Preclinical Development: Overview
5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
01:21The Nativist Approach
215
The nativist approach to infant cognitive development proposes that infants are born with inherent knowledge structures that allow them to interpret the world almost immediately. This perspective contrasts with earlier developmental theories, such as those proposed by Jean Piaget, which emphasized a more gradual acquisition of cognitive abilities through interaction with the environment. One key concept in this approach is object permanence — the understanding that objects continue to...
215